ValuentumAd

Official PayPal Seal
Fundamental data is updated weekly, as of the prior weekend. Please download the Full Report and Dividend Report for any changes.
Latest Valuentum Commentary

May 19, 2014
Merger Mania: AT&T Ties the Knot with DirecTV; Pfizer Ups Offer for AstraZeneca; Siemens Complicates Matters for GE
M&A activity continues to be robust across most sectors. Let’s take a look at three deals that continue to dominate headlines.
May 13, 2014
ALERT: AT&T Reportedly Planning to Offer Fair Value to Buy DirecTV; We Think a Higher Offer Is in the Cards
AT&T is reported to be planning to offer ~$100 per share for the pay-TV provider, but we think a higher offer may be required to seal the deal. We’re not removing the firm from the Best Ideas portfolio just yet.
May 6, 2014
DirecTV Shines in First Quarter; Merger Talk Icing on the Cake
The Best Ideas portfolio holding continues to execute well.
May 1, 2014
Highly-Rated Best Ideas Portfolio Holding DirecTV Catches a Bid
We continue to like DirecTV’s valuation, and the firm remains an acquisition target.
Mar 26, 2014
Dish Network May Finally Tie the Knot with DirecTV
Best Ideas portfolio holding DirecTV jumps on merger chatter.
Feb 20, 2014
DirecTV Posts Better-Than-Expected Fourth-Quarter Results
Best Ideas portfolio holding DirecTV continues to power ahead.
Dec 27, 2013
Quiet Trading This Week
Let’s discuss a few news items during this very quiet week of trading.
Nov 22, 2013
Merger Rumors Helping Best Ideas Portfolio Holdings
Best Ideas portfolio holdings DirecTV and Teva Pharma are getting a boost thanks to the rumor mill.
Aug 15, 2013
What’s Going on in the Time Warner-CBS Battle?
Let’s take a look at how the blackout could impact the industry landscape.
Aug 2, 2013
DirecTV’s “Miss” Mostly a Currency Issue
DirecTV is a cash cow, and we expect consolidation to benefit the industry.


Latest News and Media
The High Yield Dividend Newsletter, Best Ideas Newsletter, Dividend Growth Newsletter, Nelson Exclusive publication, and any reports, articles and content found on this website are for information purposes only and should not be considered a solicitation to buy or sell any security. The sources of the data used on this website are believed by Valuentum to be reliable, but the data’s accuracy, completeness or interpretation cannot be guaranteed. Valuentum is not responsible for any errors or omissions or for results obtained from the use of its newsletters, reports, commentary, or publications and accepts no liability for how readers may choose to utilize the content. Valuentum is not a money manager, is not a registered investment advisor and does not offer brokerage or investment banking services. Valuentum, its employees, and affiliates may have long, short or derivative positions in the stock or stocks mentioned on this site.